Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 01.04.2024 1 Am J Kidney Dis 1 Ann Neurol 1 BMC Neurol 1 Brain 10 Diabetes Res Clin Pract 7 J Autoimmun 2 J Nephrol 11 J Neurol 1 Kidney Int 3 Mult Scler 1 Neurol Clin Pract 4 Neurology 3 PLoS One 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. HONDA D, Okunaga I, Omote D, Inoue H, et al
   Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
   Am J Kidney Dis. 2024 Mar 22:S0272-6386(24)00685.
   PubMed         Abstract available
   
   

   
   Ann Neurol

2. ALPING P, Neovius M, Piehl F, Frisell T, et al
   Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting Multiple Sclerosis: A Nationwide Cost-Effectiveness Study.
   Ann Neurol. 2024 Mar 26. doi: 10.1002/ana.26914.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. KURI A, Henshall DE, Chaudhry D, Ooi SZY, et al
   Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland.
   BMC Neurol. 2024;24:105.
   PubMed         Abstract available
   
   

   
   Brain

4. MAINERO C, Miscioscia A, Treaba CA
   Cortical remyelination in multiple sclerosis: a target for disease monitoring and intervention.
   Brain. 2024 Mar 27:awae083. doi: 10.1093.
   PubMed        
   
   

   
   Diabetes Res Clin Pract

5. HATLE H, Skrivarhaug T, Bjorgaas MR, Asvold BO, et al
   Prevalence and associations of impaired awareness of hypoglycemia in a pediatric type 1 diabetes population - The Norwegian Childhood Diabetes Registry.
   Diabetes Res Clin Pract. 2024;209:111093.
   PubMed         Abstract available
   
   
6. KNAUS L, Quarella M, Buser M, Maeder MT, et al
   Screening for heart failure in patients with diabetes mellitus in tertiary care - A SwissDiab study.
   Diabetes Res Clin Pract. 2024;209:111565.
   PubMed         Abstract available
   
   
7. ZARE DEHNAVI A, Elmitwalli I, Alsharif HOH, Shervin Razavi A, et al
   Effects of ADHD and ADHD treatment on glycemic management in type 1 diabetes: A systematic review and meta-analysis of observational studies.
   Diabetes Res Clin Pract. 2024;209:111566.
   PubMed         Abstract available
   
   
8. ADDALA A, Medina Penaranda R, Naranjo D, Maahs DM, et al
   Intersectional identities play a role in perceived discrimination for families living with type 1 diabetes.
   Diabetes Res Clin Pract. 2024;209:111568.
   PubMed        
   
   
9. MINSKY N, Arnon Klug L, Kolobov T, Tarshish E, et al
   Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care.
   Diabetes Res Clin Pract. 2024;209:111587.
   PubMed         Abstract available
   
   
10. GRASSI BA, Teresa Onetto M, Sanchez C, Tapia N, et al
    Effect of low dose Semaglutide in people with Type 1 Diabetes and excess weight.
    Diabetes Res Clin Pract. 2024;209:111593.
    PubMed         Abstract available
    
    
11. LIARAKOS AL, Hasan N, Crabtree TSJ, Leelarathna L, et al
    Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study.
    Diabetes Res Clin Pract. 2024;209:111597.
    PubMed         Abstract available
    
    
12. LIN YK, Hepworth E, de Zoysa N, McCurley J, et al
    Relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes using continuous glucose monitoring systems.
    Diabetes Res Clin Pract. 2024;209:111596.
    PubMed         Abstract available
    
    
13. GENTILE S, Strollo F
    Should insulin needles be used once or several times? An unresolved conundrum.
    Diabetes Res Clin Pract. 2024;209:111600.
    PubMed        
    
    
14. PLACHY L, Neuman V, Velichova K, Slavenko MG, et al
    Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study.
    Diabetes Res Clin Pract. 2024;209:111602.
    PubMed         Abstract available
    
    

    
    J Autoimmun

15. REUSCHLE Q, Van Heddegem L, Bosteels V, Moncan M, et al
    Loss of function of XBP1 splicing activity of IRE1alpha favors B cell tolerance breakdown.
    J Autoimmun. 2024;142:103152.
    PubMed         Abstract available
    
    
16. LIBERATORE J, Nguyen Y, Hadjadj J, Cohen P, et al
    Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study.
    J Autoimmun. 2024;142:103130.
    PubMed         Abstract available
    
    
17. KELLY S, Jackson KJ, Peters TJ, Suan D, et al
    Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences.
    J Autoimmun. 2024;142:103129.
    PubMed         Abstract available
    
    
18. REYNOLDS JA, Li Y, Herlitz L, Mohan C, et al
    Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum.
    J Autoimmun. 2024;142:103134.
    PubMed         Abstract available
    
    
19. XU C, Zhang T, Wang H, Zhu L, et al
    Integrative single-cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus.
    J Autoimmun. 2024;142:103128.
    PubMed         Abstract available
    
    
20. MERINO-VICO A, van Hamburg JP, Tuijnenburg P, Frazzei G, et al
    Targeting NF-kappaB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis.
    J Autoimmun. 2024;142:103133.
    PubMed         Abstract available
    
    
21. DZIEDZIC A, Michlewska S, Jozwiak P, Debski J, et al
    Quantitative and structural changes of blood platelet cytoskeleton proteins in multiple sclerosis (MS).
    J Autoimmun. 2024;145:103204.
    PubMed         Abstract available
    
    

    
    J Nephrol

22. HU D, Wang Z, Wang S, Li Y, et al
    Lymphatic vessels in patients with crescentic glomerulonephritis: association with renal pathology and prognosis.
    J Nephrol. 2024 Mar 25. doi: 10.1007/s40620-024-01903.
    PubMed         Abstract available
    
    
23. ROBERT JT, Rajaram A, Fiset PO, Bernard C, et al
    Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist.
    J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920.
    PubMed        
    
    

    
    J Neurol

24. GOERECI Y, Ellenberger D, Rommer P, Dunkl V, et al
    Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry.
    J Neurol. 2024 Mar 22. doi: 10.1007/s00415-024-12286.
    PubMed         Abstract available
    
    
25. LAUVSNES MB, Zetterberg H, Blennow K, Kvaloy JT, et al
    Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.
    J Neurol. 2024 Mar 23. doi: 10.1007/s00415-024-12238.
    PubMed        
    
    
26. PILOTTO S, Floris M, Solla P, Pugliatti M, et al
    Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study.
    J Neurol. 2024 Mar 25. doi: 10.1007/s00415-024-12244.
    PubMed         Abstract available
    
    
27. FUCHS L, Shelly S, Vigiser I, Kolb H, et al
    Real-World experience with efgartigimod in patients with myasthenia gravis.
    J Neurol. 2024 Mar 25. doi: 10.1007/s00415-024-12293.
    PubMed         Abstract available
    
    
28. ZHANG H, Ma J, Feng Y, Ma H, et al
    Efgartigimod in the treatment of Guillain-Barre syndrome.
    J Neurol. 2024 Mar 26. doi: 10.1007/s00415-024-12321.
    PubMed         Abstract available
    
    
29. MALLUCCI G, Ferraro OE, Trojano M, Amato MP, et al
    Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score.
    J Neurol. 2024 Mar 26. doi: 10.1007/s00415-024-12304.
    PubMed         Abstract available
    
    
30. SCHALLER-PAULE MA, Maiworm M, Schafer JH, Friedauer L, et al
    Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury.
    J Neurol. 2024 Mar 27. doi: 10.1007/s00415-024-12299.
    PubMed         Abstract available
    
    
31. GUILLEMIN C, Vandeleene N, Charonitis M, Requier F, et al
    Brain microstructure is linked to cognitive fatigue in early multiple sclerosis.
    J Neurol. 2024 Mar 28. doi: 10.1007/s00415-024-12316.
    PubMed         Abstract available
    
    
32. TEDONE N, Vizzino C, Meani A, Gallo A, et al
    The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI).
    J Neurol. 2024;271:1813-1823.
    PubMed         Abstract available
    
    
33. WANG Y, Hu C, Aljarallah S, Reyes Mantilla M, et al
    Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disorders.
    J Neurol. 2024;271:1861-1872.
    PubMed         Abstract available
    
    
34. MCWILLIAM O, Gramkow MH, Blaabjerg M, Clemmensen FK, et al
    Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.
    J Neurol. 2024;271:1707-1716.
    PubMed         Abstract available
    
    

    
    Kidney Int

35. SELVASKANDAN H, Barratt J
    Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?
    Kidney Int. 2024;105:659-661.
    PubMed         Abstract available
    
    

    
    Mult Scler

36. MAILLART E, Redolfi S, Louapre C, Houot M, et al
    Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.
    Mult Scler. 2024 Mar 22:13524585241238840. doi: 10.1177/13524585241238840.
    PubMed         Abstract available
    
    
37. SORENSEN PS, Bramow S, Magyari M, Werdelin L, et al
    Torben Fog - A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research.
    Mult Scler. 2024 Mar 24:13524585241239506. doi: 10.1177/13524585241239506.
    PubMed         Abstract available
    
    
38. SIMPSON AC, Hu C, Mowry EM, Naismith RT, et al
    Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosis.
    Mult Scler. 2024 Mar 25:13524585241239473. doi: 10.1177/13524585241239473.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

39. SUZUKI S, Uzawa A, Nagane Y, Masuda M, et al
    Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.
    Neurol Clin Pract. 2024;14:e200276.
    PubMed         Abstract available
    
    

    
    Neurology

40. PAPP V, Magyari M, Moller S, Sellebjerg F, et al
    Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis Optica Spectrum Disorder Patient Cohort.
    Neurology. 2024;102:e209147.
    PubMed         Abstract available
    
    
41. DEMORTIERE S, Joubert B, Benaiteau M, Hilezian F, et al
    Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.
    Neurology. 2024;102:e209284.
    PubMed        
    
    
42. MOEHLMAN M, Kornbluh AB
    Teaching NeuroImage: Anti-NMDA Receptor Encephalitis Presenting With Cerebellitis in a Pediatric Patient.
    Neurology. 2024;102:e209259.
    PubMed        
    
    
43. 
    Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study.
    Neurology. 2024;102:e209214.
    PubMed        
    
    

    
    PLoS One

44. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    PubMed         Abstract available
    
    
45. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    PubMed         Abstract available
    
    
46. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    PubMed         Abstract available
    
    

    
    Thyroid

47. LIU S, Lu C, He L, Shan Z, et al
    Vitamin E intake and prevalence rates of thyroid dysfunction and autoimmune thyroiditis: A cross-sectional analysis of NHANES data.
    Thyroid. 2024 Mar 27. doi: 10.1089/thy.2023.0561.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.